Showing results (411-420 of 441) with videos related to
Sort By:
Pageof 45
Clinical Nutrition ESPEN|August 11, 2024
Quality-of-care standards in adult type 3 intestinal failure caused by benign disease: A European society of clinical nutrition and metabolism (ESPEN) position paperS Lal, M Soop, C Cuerda, et al.Arthritis Care & Research|June 20, 2020
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping StrategiesAliza R Karpes Matusevich, Zhigang Duan, Hui Zhao, et al.Journal of Psychiatry & Neuroscience : JPN|April 23, 1999
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variabilityR Joober, C Benkelfat, K Brisebois, et al.The Oncologist|November 20, 2024
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsJarushka Naidoo, Douglas B Johnson, Charlotte Doran, et al.The Journal of Infection|November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspectiveP K Sinha, A Ranjan, V P Singh, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 23, 2009
Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectivenessA Pantoja, K Lönnroth, S S Lal, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 23, 2009
Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patientsAndrea Pantoja, K Floyd, K P Unnikrishnan, et al.Journal of Vector Borne Diseases|December 3, 2020
Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programmeN A Siddiqui, K Pandey, V N R Das, et al.The American Journal of Tropical Medicine and Hygiene|June 6, 2012
Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, IndiaVidya Nand Rabi Das, Alok Ranjan, Krishna Pandey, et al.Infection|July 11, 2015
Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasisC S Lal, R B Verma, N Verma, et al.Pageof 45